Table 1.
The clinical and demographic characteristics of patients with lung cancer who were eligible for palliative radiotherapy (n = 72) who were enrolled in this study to investigate the relationship between haemostasis biomarkers, disease stage and tumour volume.
| Characteristic | Cohortn = 72 |
|---|---|
| Age, years | |
| Median (range) | 68 (41–86) |
| Sex | |
| Male | 40 (56) |
| Female | 32 (44) |
| Tumour histology | |
| Non-small cell carcinoma | 15 (21) |
| Adenocarcinoma | 32 (44) |
| Squamous | 15 (21) |
| Small cell carcinoma | 10 (14) |
| World Health Organization performance status | |
| 0–1 | 10 (14) |
| 2–3 | 62 (86) |
| Tumour/Node/Metastasis classification | |
| T1a/T1b/T2/T3/T4 | 2/3/12/17/38 |
| N0/N1/N2/N3 | 22/18/18/14 |
| M0/M1a/M1b | 21/4/47 |
| Tumour volume, mm3 | |
| Mean (range) | 37.8 (0.6–152.4) |
Data presented as n of patients (%), median (range) or mean (range).